4 Healthcare Stock Stories for a Midweek Investment Checkup
Sanofi-Aventis (NYSE:SNY): Closing price $47.94
On Wednesday, Sanofi US and POZEN Inc. reported the signing of an exclusive license arrangement for the commercialization of POZEN’s proprietary, investigational, coordinated-delivery tablets uniting immediate-release omeprazole, a proton pump inhibitor, and enteric-coated aspirin in a single tablet, PA8140 and PA32540.
Through the terms, Sanofi will hold exclusive rights to commercialize all PA combinations which contain 325 g or less of enteric-coated aspirin in the United States. POZEN will obtain an upfront payment of $15 million and become eligible for pre-commercial milestone payments of as much as $20 million, along with other future milestone payments and royalties on product sales.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.